Financing channel feed – Endpoints News

Financing channel feed

Chinese oncology startup Adagene closes $50M Series C led by Sequoia Capital

8 years ago

Singapore’s Aslan Pharma lines up an $86M IPO to fund pivotal cancer drug studies

8 years ago

Shanghai drugmaker Hua hauls in $117M megaround, with plans for hefty Hong Kong IPO

8 years ago

With major funding from Novartis, Surface Oncology launches a CD47 trial amid a swarm of rivals and files for $75M IPO

8 years ago

Backed in part by Roche, Denmark's NMD gets $47M to run orphan neuromuscular disease trials

8 years ago

MorphoSys files for $150M IPO to fuel its hopeful DLBCL drug launch

8 years ago

Another immunometabolism deal? Johns Hopkins spinout Dracen lands $36M investment from Deerfield

8 years ago

Third Rock debuts immunometabolism startup Rheos with $60M launch round

8 years ago

Another mega-startup: China investors back TCR2's $125M cash round to fuel a preclinical assault on solid tumors

8 years ago

Trendy anti-aging biotech Unity adds $55M as it preps first human trial to flush senescent cells

8 years ago

Alzheon files for $80M IPO to take once-failed Alzheimer's drug into PhIII

8 years ago

CRISPR pioneer Feng Zhang co-founds a 'limitless' biotech upstart with big plans for speeding new drug development

8 years ago

Hinting at an IPO and big things ahead for synthetic lethality, preclinical Ideaya touts a $94M round

8 years ago

The biotech IPO party rocks on with $120M raise for I/O player Arcus Biosciences

8 years ago

Endocrine experts at Crinetics bag $63.5M to push R&D on an experimental pill for acromegaly

8 years ago

Hua Medicine plans to join trendy Hong Kong IPO club, pitching an offering of up to $400M -- reports

8 years ago

Xeris hauls $55M in new funding to bring glucagon pen to market

8 years ago

Juno, WuXi JV gets a $90M round as China’s CAR-T pioneers fly high with fresh cash

8 years ago

Bound for the clinic with a new approach to synthetic lethality, Cyteir bags $29M

8 years ago

Prevail grabs $75M A round in the hunt for new gene therapies to stop the destruction caused by Parkinson's

8 years ago

SF tech startup Atomwise gets $45M for AI-powered drug design software

8 years ago

Oxford Vacmedix moves cancer vaccines forward with $12.5M from South Korea, China

8 years ago

Metavant makes a debut: Vivek Ramaswamy launches biotech #7 and builds a diabetes pipeline with Ligand deal

8 years ago

ViewPoint Therapeutics gets $35M to advance non-surgical alternative for cataracts, presbyopia

8 years ago

First page Previous page 130 131 132133134 135 136 Next page Last page